WiCS-LV system
DeviceWireless cardiac stimulator implant to pace the left ventricle for CRT Transvascular endocardial implantation of wireless pacing Electrode and subcutaneous implantation of Implantable Pulse Generator
Other names: Implant
NCT Number: NCT01905670
The study is intended to demonstrate the safe implant of small receiver-electrodes into the endocardial surface of the left ventricle and to demonstrate its utility in providing cardiac resynchronization therapy in heart failure patients.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Na Homolce Hospital, Prague, Czechia
Eligible patients will undergo an acoustic window assessment using transthoracic echocardiography. Patients with adequate acoustic windows will undergo implantation of the WiCS-LV system.
Patients will undergo evaluations pre-hospital discharge, and at one month, 3 months, and 6 months post implantation. Extended follow-up will be obtained via a registry at 1, 2, 3, 4, and 5 years post implantation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients with standard indications for CRT based upon the most recent ESC/EHRA guidelines AND meeting criteria for one of these two categories:
Exclusion criteria
Wireless cardiac stimulator implant to pace the left ventricle for CRT Transvascular endocardial implantation of wireless pacing Electrode and subcutaneous implantation of Implantable Pulse Generator
Other names: Implant
Time frame: 24 hour peri-operative and one month
Device-related adverse events are those in which the WiCS-LV system is directly or indirectly responsible.
Time frame: 24 hour perioperative and one month
Procedure-related adverse events are those which occur during the WiCS-LV system implant procedure.
Time frame: one month
Bi-ventricular pacing capture documented on 12-lead EKG
Time frame: 6 months
Device-related adverse events are those in which the WiCS-LV system is directly or indirectly responsible.
Time frame: 6 months
Time frame: 6 months
Bi-ventricular pacing capture documented on 12-lead EKG
Time frame: 6 months
Composite of all cause mortality, heart failure hospitalization, NYHA class, and patient global assessment
Time frame: 6 months
change in left-ventricular end-systolic volume, left ventricular end-diastolic volume, and ejection fraction
EBR Systems, Inc.
Industry
Multicenter, Prospective Evaluation of Safety and Performance of the WiCS-LV System in Patients Indicated for Cardiac Resynchronization Therapy
Acronym: SELECT-LV
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04634708
Cardiomyopathies, Cardiovascular Diseases
Berlin, Germany
View Trial DetailsNCT05868616
Cardiomyopathies, Cardiovascular Diseases
Oslo, Norway
View Trial DetailsNCT04782232
Cardiovascular Abnormalities, Cardiovascular Diseases
Munich, Germany
View Trial DetailsNCT00000547
Cardiomyopathies, Cardiovascular Diseases
View Trial Details